Bracco to construct $230 million contrast media facility in North Carolina
Italian pharmaceutical group Bracco plans to build its first U.S.-based manufacturing plant in Sanford, North Carolina, with an investment of $230 million.
Bracco, the Italian medical imaging company, has announced plans to establish its first U.S. manufacturing facility in Sanford, North Carolina. The $230 million project aims to localize the production of injectable contrast media, a critical component in diagnostic imaging.
The investment is expected to create 200 new jobs in the region. By shifting production closer to the North American customer base, the company seeks to mitigate potential supply chain disruptions and stabilize inventory levels for hospitals and clinics that rely on its diagnostic agents.
This move represents a strategic pivot for Bracco to secure its foothold in the U.S. market, which remains the largest consumer of medical imaging contrast agents globally. Construction timelines and operational commencement dates have not yet been finalized, but the facility marks a significant expansion of the company’s manufacturing footprint.